Doximity, Inc.
DOCS· NYSE
Released Feb 5, 2026, after the close
10-Q filed Feb 5, 2026, 36 days after period end · 0001516513-26-000006
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $185.05M | $168.60M | $135.28M | $115.26M |
| Net Income | $61.56M | $75.20M | $47.96M | $33.47M |
| EPS Diluted |
Doximity, Inc. · CIK 1516513 · Engraved from SEC EDGAR
| $0.31 |
| $0.37 |
| $0.24 |
| $0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.